How big is the South Africa Oral Antidiabetic Drug Market?

The South Africa Oral Antidiabetic Drug Market size is expected to reach USD 241.78 million in 2024 and grow at a CAGR of greater than 2% to reach USD 275.36 million by 2029. Read More

What is the current South Africa Oral Antidiabetic Drug Market size?

In 2024, the South Africa Oral Antidiabetic Drug Market size is expected to reach USD 241.78 million. Read More

Who are the key players in South Africa Oral Antidiabetic Drug Market?

Astrazeneca, Astellas, Janssen, Eli Lilly and Sanofi are the major companies operating in the South Africa Oral Antidiabetic Drug Market. Read More

What years does this South Africa Oral Antidiabetic Drug Market cover, and what was the market size in 2023?

In 2023, the South Africa Oral Antidiabetic Drug Market size was estimated at USD 236.94 million. The report covers the South Africa Oral Antidiabetic Drug Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the South Africa Oral Antidiabetic Drug Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

South Africa Oral Antidiabetic Drug Market Share

Statistics for the 2023 & 2024 South Africa Oral Antidiabetic Drug market share, created by Mordor Intelligence™ Industry Reports. South Africa Oral Antidiabetic Drug share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of South Africa Oral Antidiabetic Drug Industry

The South Africa oral anti-diabetes drug market is consolidated, with a few major manufacturers like Eli Lilly, AstraZeneca, Sanofi, and Janssen Pharmaceuticals having a global market presence. In contrast, the remaining manufacturers are confined to the other local or regional markets. Companies are focusing on innovations in diabetes drugs.